Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (421-430 of 460) with videos related to

Pageof 46
Sort By:
Nature Medicine|October 3, 2018
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cellMarco Ruella, Jun Xu, David M Barrett, et al.
Science Translational Medicine|February 20, 2015
Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastomaLaura A Johnson, John Scholler, Takayuki Ohkuri, et al.
Blood Advances|February 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemiaJason Xu, Michael McCoy, Zachary Martinez, et al.
Blood Advances|October 23, 2020
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill childrenCaroline Diorio, Pamela A Shaw, Edward Pequignot, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
Cell|December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
Nature Medicine|September 27, 2024
Cytokine-mediated CAR T therapy resistance in AMLAnand S Bhagwat, Leonel Torres, Olga Shestova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaRegina M Myers, Yimei Li, Allison Barz Leahy, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsHolbrook E Kohrt, Paul C Tumeh, Don Benson, et al.
Pageof 46

Showing results (421-430 of 460) with videos related to

Sort By:
Pageof 46
Nature Medicine|October 3, 2018
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cellMarco Ruella, Jun Xu, David M Barrett, et al.
Science Translational Medicine|February 20, 2015
Rational development and characterization of humanized anti-EGFR variant III chimeric antigen receptor T cells for glioblastomaLaura A Johnson, John Scholler, Takayuki Ohkuri, et al.
Blood Advances|February 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemiaJason Xu, Michael McCoy, Zachary Martinez, et al.
Blood Advances|October 23, 2020
Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill childrenCaroline Diorio, Pamela A Shaw, Edward Pequignot, et al.
Journal for Immunotherapy of Cancer|April 17, 2025
CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapyRegina M Myers, Amanda M DiNofia, Yimei Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 22, 2026
Phase I study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancersJulie S Barber-Rotenberg, Andrew R Haas, Charu Aggarwal, et al.
Cell|December 3, 2021
An NK-like CAR T cell transition in CAR T cell dysfunctionCharly R Good, M Angela Aznar, Shunichiro Kuramitsu, et al.
Nature Medicine|September 27, 2024
Cytokine-mediated CAR T therapy resistance in AMLAnand S Bhagwat, Leonel Torres, Olga Shestova, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 22, 2021
Humanized CD19-Targeted Chimeric Antigen Receptor (CAR) T Cells in CAR-Naive and CAR-Exposed Children and Young Adults With Relapsed or Refractory Acute Lymphoblastic LeukemiaRegina M Myers, Yimei Li, Allison Barz Leahy, et al.
Journal for Immunotherapy of Cancer|March 17, 2016
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trialsHolbrook E Kohrt, Paul C Tumeh, Don Benson, et al.
Pageof 46